BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10664529)

  • 1. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
    de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
    Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
    Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
    Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians.
    Nigam R; Bhatia E; Miao D; Yu L; Brozzetti A; Eisenbarth GS; Falorni A
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):593-8. PubMed ID: 14616882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
    Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
    J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
    Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
    J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease.
    Dal Pra C; Chen S; Furmaniak J; Smith BR; Pedini B; Moscon A; Zanchetta R; Betterle C
    Eur J Endocrinol; 2003 May; 148(5):565-70. PubMed ID: 12720541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.
    Brozzetti A; Marzotti S; La Torre D; Bacosi ML; Morelli S; Bini V; Ambrosi B; Giordano R; Perniola R; De Bellis A; Betterle C; Falorni A;
    Eur J Endocrinol; 2010 Aug; 163(2):309-17. PubMed ID: 20498138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
    Falorni A; Laureti S; Nikoshkov A; Picchio ML; Hallengren B; Vandewalle CL; Gorus FK; Tortoioli C; Luthman H; Brunetti P; Santeusanio F
    Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease.
    Söderbergh A; Winqvist O; Norheim I; Rorsman F; Husebye ES; Dolva O; Karlsson FA; Kämpe O
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):453-60. PubMed ID: 8959085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1.
    Bøe AS; Bredholt G; Knappskog PM; Hjelmervik TO; Mellgren G; Winqvist O; Kämpe O; Husebye ES
    Eur J Endocrinol; 2004 Jan; 150(1):49-56. PubMed ID: 14713279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.
    Laureti S; De Bellis A; Muccitelli VI; Calcinaro F; Bizzarro A; Rossi R; Bellastella A; Santeusanio F; Falorni A
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3507-11. PubMed ID: 9768655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity.
    Falorni A; Laureti S; Candeloro P; Perrino S; Coronella C; Bizzarro A; Bellastella A; Santeusanio F; De Bellis A
    Fertil Steril; 2002 Aug; 78(2):270-9. PubMed ID: 12137862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
    Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation.
    Reato G; Morlin L; Chen S; Furmaniak J; Smith BR; Masiero S; Albergoni MP; Cervato S; Zanchetta R; Betterle C
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1255-61. PubMed ID: 21677034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
    Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
    J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
    Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
    Betterle C; Dalpra C; Greggio N; Volpato M; Zanchetta R
    Ann Endocrinol (Paris); 2001 Apr; 62(2):193-201. PubMed ID: 11353894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies].
    Degros V; Pons L; Ghulam A; Racadot A
    Ann Biol Clin (Paris); 1999; 57(6):705-9. PubMed ID: 10572219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.
    Falorni A; Laureti S; De Bellis A; Zanchetta R; Tiberti C; Arnaldi G; Bini V; Beck-Peccoz P; Bizzarro A; Dotta F; Mantero F; Bellastella A; Betterle C; Santeusanio F;
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1598-604. PubMed ID: 15070918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of adrenocortical autoantibodies in Addison's disease with a peroxidase-labelled protein A technique.
    Silva RC; Faiçal S; Laureti S; Falorni A; Dib SA; Kater CE
    Braz J Med Biol Res; 1998 Sep; 31(9):1141-8. PubMed ID: 9876281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.